These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study. Qu S; Xu Z; Zhang Y; Qin T; Zhang T; Cui R; Xiao Z Leuk Lymphoma; 2012 May; 53(5):940-6. PubMed ID: 22023524 [TBL] [Abstract][Full Text] [Related]
25. Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database. Enrico A; Bestach Y; Flores MG; Arbelbide J; Serale C; Novoa V; Crisp R; Rivas MM; Larripa I; Belli C Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):743-752.e5. PubMed ID: 28797621 [TBL] [Abstract][Full Text] [Related]
26. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. Schanz J; Steidl C; Fonatsch C; Pfeilstöcker M; Nösslinger T; Tuechler H; Valent P; Hildebrandt B; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Garcia-Manero G; Kantarjian H; Germing U; Haase D; Estey E J Clin Oncol; 2011 May; 29(15):1963-70. PubMed ID: 21519021 [TBL] [Abstract][Full Text] [Related]
27. [Scoring analysis on prognosis of 63 patients with melodysplastic syndrome]. Wei J; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):305-11. PubMed ID: 18426654 [TBL] [Abstract][Full Text] [Related]
28. The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution. Zhao WL; Xu L; Wu W; Yan H; Tang W; Hu J; Chen Y; Li JM; Zeng XY; Xiong SM; Shen ZX; Chen Z; Wang ZY; Chen SJ Hematol J; 2002; 3(3):137-44. PubMed ID: 12111649 [TBL] [Abstract][Full Text] [Related]
29. A comparative review of classification systems in myelodysplastic syndromes (MDS). Bennett JM Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011 [TBL] [Abstract][Full Text] [Related]
30. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R). Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Blanco ML; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu M; Ferrer A; Sanz GF; Florensa L Am J Hematol; 2017 Jul; 92(7):614-621. PubMed ID: 28370234 [TBL] [Abstract][Full Text] [Related]
31. Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study. Wang H; Wang X; Xu X; Lin G Ann Hematol; 2010 Jun; 89(6):535-44. PubMed ID: 19921190 [TBL] [Abstract][Full Text] [Related]
32. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Kantarjian H; O'Brien S; Ravandi F; Cortes J; Shan J; Bennett JM; List A; Fenaux P; Sanz G; Issa JP; Freireich EJ; Garcia-Manero G Cancer; 2008 Sep; 113(6):1351-61. PubMed ID: 18618511 [TBL] [Abstract][Full Text] [Related]
33. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Germing U; Hildebrandt B; Pfeilstöcker M; Nösslinger T; Valent P; Fonatsch C; Lübbert M; Haase D; Steidl C; Krieger O; Stauder R; Giagounidis AA; Strupp C; Kündgen A; Mueller T; Haas R; Gattermann N; Aul C Leukemia; 2005 Dec; 19(12):2223-31. PubMed ID: 16193087 [TBL] [Abstract][Full Text] [Related]
34. Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores. Reis-Alves SC; Traina F; Harada G; Campos PM; Saad ST; Metze K; Lorand-Metze I PLoS One; 2013; 8(12):e81048. PubMed ID: 24324660 [TBL] [Abstract][Full Text] [Related]
35. WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Alessandrino EP; Della Porta MG; Bacigalupo A; Van Lint MT; Falda M; Onida F; Bernardi M; Iori AP; Rambaldi A; Cerretti R; Marenco P; Pioltelli P; Malcovati L; Pascutto C; Oneto R; Fanin R; Bosi A; Blood; 2008 Aug; 112(3):895-902. PubMed ID: 18497321 [TBL] [Abstract][Full Text] [Related]
36. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458 [TBL] [Abstract][Full Text] [Related]
37. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes]. Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954 [TBL] [Abstract][Full Text] [Related]
38. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943 [TBL] [Abstract][Full Text] [Related]
39. Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. Bernasconi P; Klersy C; Boni M; Cavigliano PM; Dambruoso I; Zappatore R Am J Hematol; 2013 Feb; 88(2):120-9. PubMed ID: 23349006 [TBL] [Abstract][Full Text] [Related]
40. Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes. Montoro J; Pomares H; Villacampa G; Merchán B; Molero A; Alonso E; Gallur L; Grau J; Salamero O; Roldán E; Saumell S; Ortega M; Sureda A; Bosch F; Arnan M; Valcárcel D Leuk Lymphoma; 2019 Jun; 60(6):1522-1527. PubMed ID: 30499738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]